Moleculin Biotech, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $285.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2017-11-13
- Moleculin Biotech, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-09-30 was $445.00K, a 61.82% increase year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-06-30 was -$209.00K.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-03-31 was $49.00K, a 22.50% increase year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-12-31 was $105.87K.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was -$41.13K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 2 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 5 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $236.00K derived: sum of 2 quarters · filed 2017-11-13 | $285.00K 10-Q · filed 2017-11-13 | $390.87K derived: sum of 4 quarters · filed 2017-11-13 | |||||
| 2017-06-30 | -$209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$160.00K 10-Q · filed 2017-08-11 | -$54.13K derived: sum of 3 quarters · filed 2017-08-11 | $220.87K derived: sum of 4 quarters · filed 2017-11-13 | |||||
| 2017-03-31 | $49.00K 10-Q · filed 2017-05-12 | $154.87K derived: sum of 2 quarters · filed 2017-05-12 | $429.87K derived: sum of 3 quarters · filed 2017-11-13 | -$32.13K derived: sum of 4 quarters · filed 2017-11-13 | |||||
| 2016-12-31 | $105.87K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03 | $380.87K derived: sum of 2 quarters · filed 2017-11-13 | -$81.13K derived: sum of 3 quarters · filed 2017-11-13 | -$41.13K 10-K · filed 2017-04-03 | |||||
| 2016-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$187.00K derived: sum of 2 quarters · filed 2017-11-13 | -$147.00K 10-Q · filed 2017-11-13 | -$146.80K 10-Q · filed 2016-11-21 | |||||
| 2016-06-30 | -$462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$422.00K 10-Q · filed 2017-08-11 | -$421.94K 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | $40.00K 10-Q · filed 2017-05-12 | $40.21K 10-Q · filed 2016-06-16 | |||||||
| 2015-12-31 | $322.79K 10-K · filed 2017-04-03 | ||||||||
| 2015-09-30 | $63.01K 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |